The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts

Journal of Cellular Biochemistry

Volumn 107, Issue 1, 2009, Pages 144-154

  Teplyuk, Nadiya M ^a   Haupt, Larisa M ^b,d   Ling, Ling ^b   Dombrowski, Christian ^b   Foong, Kin Mun ^b   Nathan, Saminathan S ^c   Lian, Jane B ^a   Stein, Janet L ^a   Stein, Gary S ^a   Cool, Simon M ^b,c   Van Wijnen, Andre J ^a,e  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d GRIFFITH UNIVERSITY   (Australia)

^e Department of Cell Biology ^*  (United States)

Author keywords

Fibroblast growth factor; Glycosaminoglycan; Glypican; Heparan sulfate; Heparin; Osteoblast; Proteoglycan; Runx2; Syndecan

Indexed keywords

ALKALINE PHOSPHATASE; CHONDROITIN SULFATE; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARANASE; OSTEOCALCIN; OSTEOPONTIN; PROTEOGLYCAN; SULFATASE; SULFOTRANSFERASE; SYNDECAN 4; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE GROWTH; CELL MATURATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GROWTH REGULATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; STEM CELL;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEEDBACK, BIOCHEMICAL; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; OSTEOGENESIS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 66149160499     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22108     Document Type: Article

References (51)

1. Bae JS, Gutierrez S, Narla R, Pratap J, Devados R, van Wijnen AJ, Stein JL, Stein GS, Lian JB, Javed A. 2007. Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation. J Cell Biochem 100:434-449.
2. Bodo M, Baroni T, Carinci F, Becchetti E, Bellucci C, Conte C, Pezzetti F, Evangelisti R, Tognon M, Carinci P. 1999. A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndrome. Eur J Cell Biol 78:323-330.
3. Bonaventure J, El Ghouzzi V. 2003. Molecular and cellular bases of syndromic craniosynostoses. Expert Rev Mol Med 5:1-17.
4. Boudreaux JM, Towler DA. 1996. Synergistic induction of osteocalcin gene expression: Identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteocalcin promoter. J Biol Chem 271:7508-7515.
5. Coffin JD, Florkiewicz RZ, Neumann J, Mort-Hopkins T, Dorn GW, Lightfoot P, German R, Howles PN, Kier A, O'Toole BA. 1995. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF- 2) transgenic mice. Mol Biol Cell 6:1861-1873.
6. Cunningham ML, Seto ML, Ratisoontorn C, Heike CL, Hing AV. 2007. Syndromic craniosynostosis: From history to hydrogen bonds. Orthod Craniofac Res 10:67-81.
7. De Cat B, David G. 2001. Developmental roles of the glypicans. Semin Cell Dev Biol 12:117-125.
8. Dennis G, Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 4:3.
9. Galindo M, Pratap J, Young DW, Hovhannisyan H, Im HJ, Choi JY, Lian JB, Stein JL, Stein GS, van Wijnen AJ. 2005. The bone-specific expression of RUNX2 oscillates during the cell cycle to support a G1 related anti-proliferative function in osteoblasts. J Biol Chem 280:20274-20285.
10. Galindo M, Teplyuk N, Yang X, Young DW, Javed A, Lian JB, Stein JL, Stein GS, van Wijnen AJ. 2006. Post-mitotic expression of transcription factor RUNX2 defines a novel regulatory transition during the G1 phase of proliferating pre-osteoblasts. J Bone Miner Res 21:S384.
11. Galindo M, Kahler RA, Teplyuk NM, Stein JL, Lian JB, Stein GS, Westendorf JJ, van Wijnen AJ. 2007. Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancer-binding factor 1 (Lef1) in proliferating osteoblasts. J Mol Histol 38:501-506.
12. Gorsi B, Stringer SE. 2007. Tinkering with heparan sulfate sulfation to steer development. Trends Cell Biol 17:173-177.
13. Gutierrez GM, Kong E, Sabbagh Y, Brown NE, Lee JS, Demay MB, Thomas DM, Hinds PW. 2008. Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1-/- mice. Proc Natl Acad Sci USA 105:18402-18407.
14. Hatch NE, Li Y, Franceschi RT. 2008. FGF2 stimulation of the pyrophosphate generating enzyme, PC-1, in pre-osteoblast cells is mediated by RUNX2. J Bone Miner Res [Epub ahead of print].
15. Hoffmann R, Valencia A. 2004. A gene network for navigating the literature. Nat Genet 36:664.
16. Jackson RA, Kumarasuriyar A, Nurcombe V, Cool SM. 2006a. Long-term loading inhibits ERK1/2 phosphorylation and increases FGFR3 expression in MC3T3-E1 osteoblast cells. J Cell Physiol 209:894-904.
17. Jackson RA, Nurcombe V, Cool SM. 2006b. Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 379:79-91.
18. Jackson RA, Murali S, van Wijnen AJ, Stein GS, Nurcombe V, Cool SM. 2007. Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2. J Cell Physiol 210:38-50.
19. Javed A, Bae JS, Afzal F, Gutierrez S, Pratap J, Zaidi SK, Lou Y, van Wijnen AJ, Stein JL, Stein GS, Lian JB. 2008. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 283:8412-8422.
20. Jensen ED, Niu L, Caretti G, Nicol SM, Teplyuk N, Stein GS, Sartorelli V, van Wijnen AJ, Fuller-Pace FV, Westendorf JJ. 2008. p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation. J Cell Biochem 103:1438-1451.
21. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM. 2003. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278:319-326.
22. Kim BG, Kim HJ, Park HJ, Kim YJ, Yoon WJ, Lee SJ, Ryoo HM, Cho JY. 2006. Runx2 phosphorylation induced by fibroblast growth factor-2/protein kinase C pathways. Proteomics 6:1166-1174.
23. Lamanna WC, Kalus I, Padva M, Baldwin RJ, Merry CL, Dierks T. 2007. The heparanome - The enigma of encoding and decoding heparan sulfate sulfation. J Biotechnol 129:290-307.
24. Lee JY, Choo JE, Choi YS, Lee KY, Min DS, Pi SH, Seol YJ, Lee SJ, Jo IH, Chung CP, Park YJ. 2007. Characterization of the surface immobilized synthetic heparin binding domain derived from human fibroblast growth factor-2 and its effect on osteoblast differentiation. J Biomed Mater Res A 83:970-979.
25. Ling L, Murali S, Dombrowski C, Haupt LM, Stein GS, van Wijnen AJ, Nurcombe V, Cool SM. 2006. Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells. J Cell Physiol 209:811-825.
26. Ling L, Nurcombe V, Cool SM. 2009. Wnt signaling controls the fate of mesenchymal stem cells. Gene 433(1-2):1-7.
27. Marie PJ. 2003. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316:23-32.
28. Marie PJ, Coffin JD, Hurley MM. 2005. FGF and FGFR signaling in chondrodysplasias and craniosynostosis. J Cell Biochem 96:888-896.
29. Molteni A, Modrowski D, Hott M, Marie PJ. 1999. Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro. Bone 24:337-347.
30. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM. 2000. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093.
31. Naganawa T, Xiao L, Abogunde E, Sobue T, Kalajzic I, Sabbieti M, Agas D, Hurley MM. 2006. In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice. Biochem Biophys Res Commun 339:490-498.
32. Nathan SS, Pereira BP, Zhou YF, Gupta A, Dombrowski C, Soong R, Pho RW, Stein GS, Salto-Tellez M, Cool SM, van Wijnen AJ. 2008. Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma. Mol Biol Rep 36:153-158.
33. Ng KW, Speicher T, Dombrowski C, Helledie T, Haupt LM, Nurcombe V, Cool SM. 2007. Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptors. Stem Cells Dev 16:305-318.
34. Okazaki R, Ikeda K, Sakamoto A, Nakano T, Morimoto K, Kikuchi T, Urakawa K, Ogata E, Matsumoto T. 1992. Transcriptional activation of c-fos and c-jun protooncogenes by serum growth factors in osteoblast-like MC3T3-E1 cells. J Bone Miner Res 7:1149-1155.
35. Pratap J, Galindo M, Zaidi SK, Vradii D, Bhat BM, Robinson JA, Choi J-Y, Komori T, Stein JL, Lian JB, Stein GS, van Wijnen AJ. 2003. Cell growth regulatory role of Runx2 during proliferative expansion of pre-osteoblasts. Cancer Res 63:5357-5362.
36. Pratap J, Lian JB, Javed A, Barnes GL, van Wijnen AJ, Stein JL, Stein GS. 2006. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev 25:589-600.
37. Rajgopal A, Young DW, Mujeeb KA, Stein JL, Lian JB, van Wijnen AJ, Stein GS. 2007. Mitotic control of RUNX2 phosphorylation by both CDK1/cyclin B kinase and PP1/PP2A phosphatase in osteoblastic cells. J Cell Biochem 100:1509-1517.
38. Sabbieti MG, Agas D, Materazzi S, Capacchietti M, Materazzi G, Hurley MM, Menghi G, Marchetti L. 2008. Prostaglandin F2alpha involves heparan sulphate sugar chains and FGFRs to modulate osteoblast growth and differentiation. J Cell Physiol 217:48-59.
39. Shimizu-Sasaki E, Yamazaki M, Furuyama S, Sugiya H, Sodek J, Ogata Y. 2001. Identification of a novel response element in the rat bone sialoprotein (BSP) gene promoter that mediates constitutive and fibroblast growth factor 2-induced expression of BSP. J Biol Chem 276:5459-5466.
40. Sobue T, Naganawa T, Xiao L, Okada Y, Tanaka Y, Ito M, Okimoto N, Nakamura T, Coffin JD, Hurley MM. 2005. Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice. J Cell Biochem 95:83-94.
41. Song SJ, Cool SM, Nurcombe V. 2007. Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2. J Cell Biochem 100:402-411.
42. Teplyuk NM, Galindo M, Teplyuk VI, Pratap J, Young DW, Lapointe D, Javed A, Stein JL, Lian JB, Stein GS, van Wijnen AJ. 2008. Runx2 regulates Gprotein coupled signaling pathways to control growth of osteoblast progenitors. J Biol Chem 283:27585-27597.
43. Thomas DM, Johnson SA, Sims NA, Trivett MK, Slavin JL, Rubin BP, Waring P, McArthur GA, Walkley CR, Holloway AJ, Diyagama D, Grim JE, Clurman BE, Bowtell DD, Lee JS, Gutierrez GM, Piscopo DM, Carty SA, Hinds PW. 2004. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J Cell Biol 167:925-934.
44. van Wijnen AJ, Stein GS, Gergen JP, Groner Y, Hiebert SW, Ito Y, Liu P, Neil JC, Ohki M, Speck N. 2004. Nomenclature for Runt-related (RUNX) proteins. Oncogene 23:4209-4210.
45. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT. 2002. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 277:36181-36187.
46. Young DW, Hassan MQ, Pratap J, Galindo M, Zaidi SK, Lee SH, Yang X, Xie R, Javed A, Underwood JM, Furcinitti P, Imbalzano AN, Penman S, Nickerson JA, Montecino MA, Lian JB, Stein JL, van Wijnen AJ, Stein GS. 2007a. Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature 445:442-446.
47. Young DW, Hassan MQ, Yang X-Q, Galindo M, Javed A, Zaidi SK, Furcinitti P, Lapointe D, Montecino M, Lian JB, Stein JL, van Wijnen AJ, Stein GS. 2007b. Mitotic retention of gene expression patterns by the cell fate determining transcription factor Runx2. Proc Natl Acad Sci USA 104:3189-3194.
48. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA, Ornitz DM. 2003. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130:3063-3074.
49. Zaidi SK, Young DW, Pockwinse SH, Javed A, Lian JB, Stein JL, van Wijnen AJ, Stein GS. 2003. Mitotic partitioning and selective reorganization of tissue specific transcription factors in progeny cells. Proc Natl Acad Sci USA 100:14852-14857.
50. Zaidi SK, Pande S, Pratap J, Gaur T, Grigoriu S, Ali SA, Stein JL, Lian JB, van Wijnen AJ, Stein GS. 2007. Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential. Proc Natl Acad Sci USA 104:19861-19866.
51. Zhang X, Sobue T, Hurley MM. 2002. FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cells. Biochem Biophys Res Commun 290:526-531.